Integrated Medical Professionals 2024 Coding Seminar

Sunday, February 4, 2024, 8:00 AM - 12:30 PM, Virtual Webinar


The coding seminar will emphasize coding changes and updates on the urology practice. It will introduce codes that were established by RSV (Relative Value Scale) Update Committee (RUC). Risk Management in the practice will be discussed in terms of proper coding technique, documentation and incident to billing. It will also address up to date information related to urology news nationally.

1. Distinguish new ICD-10 and codes
2. Illustrate and Identify the new or updated legislation that affects urology care nationally.
3. Identify new urology CPT codes
4. Evaluate and Discuss the importance of proper documentation.

Registration is Complimentary

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (3.75 hours), Non-Physician Attendance (3.75 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of Icahn School of Medicine at Mount Sinai (ISMMS) to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-accredited educational activities. All faculty participating in the planning or implementation of an activity accredited by ISMMS are expected to disclose all of their financial relationships with ineligible companies existing within the prior 24 months. Relevant financial relationships will be mitigated and disclosed to learners before the activity takes place. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Sunday, February 4, 2024